Role of ALK5/SMAD2/3 signaling in the regulation of NOX expression in cerebral ischemia/reperfusion injury.

Lou, Zheng; Wang, Ai-Ping; Duan, Xiao-Ming; Hu, Guo-Huang; Zuo, Mei-Ling; Yang, Zhong-Bao.

Afiliação

Lou Z; Key Laboratory Breeding Base of Hunan Oriented Fundamental and Applied Research of Innovative Pharmaceutics, Changsha Medical University, Changsha, Hunan 410219, P.R. China.
Wang AP; Department of Anatomy, School of Medicine, University of South China, Hengyang, Hunan 421001, P.R. China.
Duan XM; Department of Pharmacy, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410006, P.R. China.
Hu GH; Department of Pharmacy, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410006, P.R. China.
Zuo ML; Department of Pharmacy, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410006, P.R. China.
Yang ZB; Department of Pharmacy, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410006, P.R. China.

Exp Ther Med ; 16(3): 1671-1678, 2018 Sep.

Article em En | MEDLINE | ID: mdl-30186386

Palavras-chave

activin receptor-like kinase 5/SMAD2/3 signaling; cerebral ischemia/reperfusion injury; nicotinamide adenine dinucleotide phosphate oxidase 2; nicotinamide adenine dinucleotide phosphate oxidase 4; reactive oxygen species

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article